MyFinsight
Home
Blog
About
Tivic Health Systems, Inc. (TIVC)
Tivic Health Systems, Inc. (TIVC)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$7,037K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of prefer...
Proceeds from issuance of common...
Stock based compensation
Others
Negative Cash Flow Breakdown
Acquisition of licensed technolo...
Net cash used in operating activ...
Issuance costs in connection wit...
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2025-12-31
Research and development
3,131
Selling, general and administrative
4,767
Total operating expenses
7,898
Net other (expense) income
-95
Net loss from continuing operations
-7,993
Stock based compensation
564
Depreciation
5
Amortization of debt discount and debt issuance costs
97
Non-cash interest expense
48
Change in fair value of derivative liability
28
Issuance of warrants for services
93
Amortization of right-of-use asset
0
Write-off offering costs related to unclosed financing arrangements
143
Prepaid expenses and other current assets
-78
Other assets
0
Accounts payable
139
Accrued expenses
235
Lease liabilities
0
Net cash used in operating activities - continuing operations
-6,619
Net cash used in operating activities - discontinued operations
-380
Net cash used in operating activities
-6,999
Issuance of note receivable
124
Acquisition of property and equipment
38
Acquisition of licensed technology
543
Net cash used in investing activities
-705
Issuance costs in connection with senior convertible note
172
Proceeds from issuance of common stock, net of issuance costs
2,337
Proceeds from issuance of common stock and warrants, net of issuance costs
0
Proceeds from issuance of preferred stock and warrants, net of issuance costs
16,209
Proceeds from warrant exercises
109
Offering costs in advance of sale of common stock
136
Net cash provided by financing activities
18,347
Net increase (decrease) in cash and cash equivalents
10,643
Beginning of period
2,002
End of period
12,645
Less cash and cash equivalents included in discontinued operations
0
Cash and cash equivalents included in continuing operations
12,645
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
preferred stock and...
$16,209K
Proceeds from issuance of
common stock, net of...
$2,337K
Proceeds from warrant
exercises
$109K
Net cash provided by
financing activities
$18,347K
Canceled cashflow
$308K
Net increase
(decrease) in cash and cash...
$10,643K
Canceled cashflow
$7,704K
Issuance costs in
connection with senior...
$172K
Offering costs in advance
of sale of common...
$136K
Net cash used in
operating activities
-$6,999K
Net cash used in
investing activities
-$705K
Stock based
compensation
$564K
Accrued expenses
$235K
Write-off offering costs
related to unclosed...
$143K
Accounts payable
$139K
Amortization of debt discount
and debt issuance...
$97K
Issuance of warrants for
services
$93K
Prepaid expenses and
other current assets
-$78K
Non-cash interest
expense
$48K
Depreciation
$5K
Net cash used in
operating activities -...
-$6,619K
Net cash used in
operating activities -...
-$380K
Acquisition of licensed
technology
$543K
Issuance of note
receivable
$124K
Acquisition of property and
equipment
$38K
Canceled cashflow
$1,402K
Net loss from
continuing operations
-$7,993K
Change in fair value of
derivative liability
$28K
Total operating
expenses
$7,898K
Net other (expense)
income
-$95K
Selling, general and
administrative
$4,767K
Research and development
$3,131K
Buy us a coffee